Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, and RNA modifications and cancer.
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients
Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV)
Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004)
USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning
The genomic architecture of EBV and infected gastric tissue from precursor lesions to carcinoma
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer
Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer
Hyaluronan‐mediated motility receptor confers resistance to chemotherapy <i>via</i> TGFβ/Smad2‐induced epithelial‐mesenchymal transition in gastric cancer
Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling
Rlim, an E3 ubiquitin ligase, influences the stability of Stathmin protein in human osteosarcoma cells
miR-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation